Kissei Pharmaceutical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KSPHF research report →
Price Chart
About the company
Kissei Pharmaceutical Co. , Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
- CEO
- Mutsuo Kanzawa
- IPO
- 2017
- Employees
- 1,786
- HQ
- Matsumoto, NA, JP
Get TickerSpark's AI analysis on KSPHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $1.02B
- P/E
- 10.98
- Fwd P/E
- 0.08
- PEG
- 0.67
- P/S
- 1.56
- P/B
- 0.67
- EV/EBITDA
- 7.34
- Div Yield
- 5.53%
- Gross Margin
- 46.83%
- Op Margin
- -3.99%
- Net Margin
- 14.18%
- ROE
- 6.31%
- ROIC
- -1.27%
Latest fiscal year · YoY change
- Revenue
- $98.02B+11.0%
- Gross Profit
- $46.11B+4.6%
- Op Income
- $-2,944,417,531
- Net Income
- $13.87B+15.9%
- EPS
- $333.94+21.8%
- OCF Growth
- -122.9%
- FCF Growth
- -529.8%
- 52W High
- $31.90
- 52W Low
- $24.50
- 50D MA
- $25.64
- 200D MA
- $26.06
- Beta
- 0.40
- RSI (14)
- 0
- Avg Volume
- 9
No earnings-call transcripts are available for KSPHF yet.
- Free Float
- 56.9%
- Shares Outstanding
- 41.45M
- Float Shares
- 23.58M
Our KSPHF coverage
Recent articles, reports, and earnings notes.
No research on KSPHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KSPHF report →